First Booster of SARS-COV-2 mRNA Vaccine Is Not Associated With Alloimmunization and Subclinical Injury of Kidney Allograft
Language English Country United States Media print-electronic
Document type Letter, Research Support, Non-U.S. Gov't
PubMed
36314999
DOI
10.1097/tp.0000000000004421
PII: 00007890-202302000-00040
Knihovny.cz E-resources
- MeSH
- Allografts MeSH
- Anemia, Hemolytic, Autoimmune * MeSH
- COVID-19 * prevention & control MeSH
- Kidney MeSH
- Humans MeSH
- mRNA Vaccines MeSH
- Antibodies, Viral MeSH
- SARS-CoV-2 MeSH
- COVID-19 Vaccines * administration & dosage MeSH
- Check Tag
- Humans MeSH
- Publication type
- Letter MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Antibodies, Viral MeSH
- COVID-19 Vaccines * MeSH
Department of Nephrology Institute for Clinical and Experimental Medicine Prague Czech Republic
Immunogenetics Department Institute for Clinical and Experimental Medicine Prague Czech Republic
Transplant Laboratory Institute for Clinical and Experimental Medicine Prague Czech Republic
See more in PubMed
Levin EG, Lustig Y, Cohen C, et al. Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months. N Engl J Med. 2021;385:e84.
American Society of Transplantation. COVID-19 vaccine FAQ sheet (updated 5/4/2022). 2022. Available at https://www.myast.org/sites/default/files/2022.05.04%20AST%20Vaccine%20FAQ-CLEAN.pdf . Accessed June 16, 2022.
Goldman M. The safety of anti-SARS-CoV-2 vaccines: vigilance is still required. J Clin Med. 2022;11:1248.
Medina-Pestana J, Almeida Viana L, Nakamura MR, et al. Immunogenicity after a heterologous BNT262b2 versus homologous booster in kidney transplant recipients receiving 2 doses of coronavac vaccine: a prospective cohort study. Transplantation. [Epub ahead of print. August 5, 2022]. doi:10.1097/TP.0000000000004260 DOI
Locke JE, Zachary AA, Warren DS, et al. Proinflammatory events are associated with significant increases in breadth and strength of HLA-specific antibody. Am J Transplant. 2009;9:2136–2139.
Halloran PF, Reeve J, Madill-Thomsen KS, et al. The Trifecta study: comparing plasma levels of donor-derived cell-free DNA with the molecular phenotype of kidney transplant biopsies. J Am Soc Nephrol. 2022;33:387–400.
Oellerich M, Sherwood K, Keown P, et al. Liquid biopsies: donor-derived cell-free DNA for the detection of kidney allograft injury. Nat Rev Nephrol. 2021;17:591–603.
Park S, Guo K, Heilman RL, et al. Combining blood gene expression and cellfree DNA to diagnose subclinical rejection in kidney transplant recipients. Clin J Am Soc Nephrol CJASN. 2021;16:1539–1551.
Paul RS, Almokayad I, Collins A, et al. Donor-derived cell-free DNA: advancing a novel assay to new heights in renal transplantation. Transplant Direct. 2021;7:e664.
Süsal C, Wettstein D, Döhler B, et al. Association of kidney graft loss with de novo produced donor-specific and non-donor-specific HLA antibodies detected by single antigen testing. Transplantation. 2015;99:1976–1980.
Eurotransplant. Virtual PRA calculator. 2022. Available at https://www.etrl.org/vPRA.aspx .
